CLINICAL_TRIALS
research
· 2014-11-19
Clinical Trial Update: Italian Diffuse/Multivessel Disease ABSORB Prospective Registry: IT-Disappears [Phase 4]
Summary
Phase 4 prospective registry IT-Disappears evaluating the use of ABSORB bioresorbable vascular scaffolds in Italian patients with diffuse or multivessel coronar…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio | Conditions: Coronary Artery Disease | Phase 4 | Status: UNKNOWN